Welcome to SGC

The SGC embarks on a new project as part of the EUbOPEN Consortium

The consortium consists of 22 partners that will work together to develop high quality chemical tools

Rapidly Emerging Antiviral Drug Development Initiative (READDI)

Open science drug discovery partnership, READDI, aims to invest $125 million to prevent future pandemics

New Open-AD Drug Discovery Center

SGC and collaborators to create open research tools for Alzheimer’s disease research funded by National Institute on Aging

Discovery of a chemical probe for PRDM9

A collaboration between MSD and the SGC has resulted in the discovery of MRK-740, a potent inhibitor of PRDM9

MTase Chemical Probe Toolbox

A collection of well-characterized chemical probes and related reagents for the study of methylation-mediated signaling.

Latest Structures

TMPRSS2: Human Transmembrane protease serine 2, SRCR and serine protease domains, in complex with Nafamostat

RBBP7: Human histone-binding protein RBBP7

PPP1R10: Serine/threonine-protein phosphatase 1 regulatory subunit 10, PPP1R10, N-terminal TFIIS domain, fused to Myc Homology Box 0

WHSC1: Human Histone-lysine N-methyltransferase NSD2, first PWWP domain, in complex with MRT10241866a

BRD1: Human Bromodomain-containing protein 1, PWWP domain, in complex with DNA

CORO6: Human Coronin-6, WDR domain

EED: Human Polycomb protein EED, WDR domain, in complex with Astemizole

New Publications

Controlling Intramolecular Interactions in the Design of Selective, High-Affinity Ligands for the CREBBP Bromodomain.

J Med Chem

Opinion: Independent third-party entities as a model for validation of commercial antibodies.

N Biotechnol

NEK5 activity regulates the mesenchymal and migratory phenotype in breast cancer cells.

Breast Cancer Res Treat

Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.

SLAS Discov

MYC protein interactors in gene transcription and cancer.

Nat Rev Cancer

Genetic Variability of the SARS-CoV-2 Pocketome.

J Proteome Res

Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.

Sci Rep

Chemical Probes

SGC-SMARCA-BRDVIII - A Chemical Probe for SMARCA2/4 and PB1(5)

22nd December 2020

NR162 - A chemical probe for CASK

1st September 2020

PFI-6 - A novel chemical probe for MLLT1/3

23rd June 2020

SGC-CK2-1 - A chemical probe for CK2

11th June 2020

News from SGC

Promising new approach to stop growth of brain cancer cells

Posted on 12th February 2021

Cheryl Arrowsmith of SGC-Toronto elected a Fellow of the Royal Society of Canada

Posted on 10th September 2020

Structure of LRRK2 in Parkinson’s disease and model for microtubule interaction

Posted on 1st September 2020

Focus on...

Protein Kinases at SGC

With the involvement of:

Alex Bullock
Growth Factor Signalling
Stefan Knapp
Chemical Biology
Jon Elkins
Kinases
Brian Marsden
Research Informatics

SGC Careers

There are currently no open vacancies with the SGC. Please check back periodically for opportunities which may arise in any of our sites.

SGC Careers page